← Back to all trials
Recruiting
NCT05606822
Endoscopic Vacuum Therapy for Transmural Defects in the Upper Gastrointestinal Tract
Conditions: Endoscopic Vacuum Therapy, Anastomotic Leak, Esophageal Perforation, Esophageal Perforation, Traumatic, EsoSponge, VACStent
Sex: All
Ages: 18 Years – N/A
Enrollment: 100
Sponsor: Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
Location: Netherlands
Summary
The goal of this observational study is to learn about the best indications and techniques regarding endoscopic vacuum therapy (EVT) in patients with a transmural defect in the upper gastrointestinal (GI) tract (e.g.
anastomotic leakage, Boerhaave syndrome, iatrogenic perforation, other).
The main questions it aims to answer are:What is the success rate of EVT for transmural defects in the upper GI tract?What are the best indications for EVT in the upper GI tract?
(e.g.
etiology, patient characteristics, defect characteristics)What are the best techniques for EVT in the upper GI tract?
(e.g.
EsoSponge, VACStent, vacuum pressure, intraluminal/intracavitary) Participants will be asked for informed consent to retrospectively and prospectively collect data on EVT.
Eligibility Criteria
Inclusion Criteria:Treated with EVT for anastomotic leakage after esophago-gastric surgerySigned informed consent form18 years or olderExclusion Criteria:No signed informed consent
Source: ClinicalTrials.gov (NCT05606822). StuddyBuddy aggregates publicly available trial information.
